Understanding the impact of two malaria threats in sub-Saharan Africa

Quantifying the dual threat of Plasmodium vivax and Anopheles stephensi in a P. falciparum endemic pre-elimination setting in sub-Saharan Africa

NIH-funded research Duke University · NIH-10897329

This study is looking into how Plasmodium vivax malaria and the Anopheles stephensi mosquito are spreading in northern Kenya, especially in areas where people thought they were safe from malaria, to help improve ways to control the disease in the region.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionDuke University NIH-funded
Lab location1 site (Durham, United States)
Project IDNIH-10897329 on NIH RePORTER

What this research studies

This research investigates the presence and transmission dynamics of Plasmodium vivax malaria and the Anopheles stephensi mosquito in northern Kenya, an area approaching malaria elimination. It aims to quantify the potential risk posed by these factors, particularly in Duffy-negative populations who were previously thought to be immune. The study will involve field data collection and modeling to assess the implications for malaria control strategies in the region. By focusing on Turkana County, where P. vivax has been recently documented, the research seeks to fill critical knowledge gaps about malaria transmission in this context.

Who could benefit from this research

Good fit: Ideal candidates for participation or benefit from this research include individuals living in Turkana County, Kenya, particularly those who may be at risk for malaria infection.

Not a fit: Patients living outside of the study area or those who are not at risk for malaria infection may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved malaria control strategies that effectively address both P. vivax and An. stephensi, ultimately reducing malaria cases in affected populations.

How similar studies have performed: While there is emerging evidence regarding the presence of P. vivax in sub-Saharan Africa, this specific approach to quantify its impact alongside An. stephensi is novel and has not been extensively tested.

Where this research is happening

Durham, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.